Park Medi Extends Rally as Healthcare Expansion, Strong Fundamentals Boost Investor Confidence

Operational indicators have also remained encouraging. During the first nine months of FY26, occupancy levels improved to 65%, while Average Revenue Per Occupied Bed (ARPOB) stood at ₹27,406, indicating a gradual shift toward higher-value treatments and a better patient mix. Brokerage firm Khandwala Securities noted that stable patient volumes and improving treatment quality continue to support revenue growth and profitability.

India’s healthcare sector has also witnessed significant structural expansion, growing from US$110 billion in 2016 to US$372 billion in 2023, with estimates projecting the market to reach US$638 billion by 2025. Analysts expect companies with scalable hospital networks and affordable care models to benefit the most from this long-term demand cycle.

The brokerage further highlighted that low bed density across North India, rising healthcare awareness, and increasing formalisation of the sector provide strong tailwinds for the company. Park Medi plans to expand its capacity to more than 5,000 beds by FY28, while maintaining a near debt-free balance sheet and stable margins.

Given its aggressive expansion pipeline, healthy financial position, and improving operational metrics, Khandwala Securities has maintained an ‘Overweight’ rating on the stock, citing strong long-term revenue visibility and sustained growth potential.